Regeneron Pharmaceuticals, Inc. (TICKER: REGN) 10k Revenue Data

The gross revenue for Regeneron Pharmaceuticals, Inc. was $8,497,100,000.00 in 2020. The gross revenue for Regeneron Pharmaceuticals, Inc. was $6,557,600,000.00 in 2019. The gross revenue for Regeneron Pharmaceuticals, Inc. was $5,872,200,000.00 in 2017. The gross revenue for Regeneron Pharmaceuticals, Inc. was $5,145,600,000.00 in 2018. The gross revenue for Regeneron Pharmaceuticals, Inc. was $4,860,400,000.00 in 2016. The gross revenue for Regeneron Pharmaceuticals, Inc. was $4,103,728,000.00 in 2015. The gross revenue for Regeneron Pharmaceuticals, Inc. was $2,819,557,000.00 in 2014. The gross revenue for Regeneron Pharmaceuticals, Inc. was $2,104,745,000.00 in 2013. The gross revenue for Regeneron Pharmaceuticals, Inc. was $16,071,700,000.00 in 2021. The gross revenue for Regeneron Pharmaceuticals, Inc. was $1,378,477,000.00 in 2012. The gross revenue for Regeneron Pharmaceuticals, Inc. was $$12,173,000,000 in 2022. The gross margin for Regeneron Pharmaceuticals, Inc. was $41.03% in 2022.